Greenfield Seitz Capital Management, LLC Abb Vie Inc. Transaction History
Greenfield Seitz Capital Management, LLC
- $310 Billion
- Q3 2025
A detailed history of Greenfield Seitz Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Greenfield Seitz Capital Management, LLC holds 3,888 shares of ABBV stock, worth $909,792. This represents 0.29% of its overall portfolio holdings.
Number of Shares
3,888
Previous 3,888
-0.0%
Holding current value
$909,792
Previous $722 Million
24.74%
% of portfolio
0.29%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,485Shares Held
1.28BCall Options Held
17.1MPut Options Held
15.4M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...